Language
Company Profile
Lansion Biotechnology Co., Ltd.(Lansionbio) was established in Nanjing, China in 2016. As one high-tech enterprise and key technology-based enterprise, Lansionbio is committed to the research & development, production, sales and service of in vitro diagnostic reagents and devices. Through the integrated multi-platform POCT workstation, it provides medical units and families with comprehensive solutions for on-site rapid detection, and has become a representative enterprise of the new generation of laboratory medicine industry ecology in China.
Since 2020, Lansionbio has been actively involved in the prevention and control of the global COVID-19 epidemic, and its related products have obtained CE certification and product registration in many countries, and are exported to more than 50 countries and regions outside of China.
In the future, Lansionbio will adhere to the tenet of "Strive for excellence, care for every life and health", focus on innovation and quality, and devote itself to improving human health by providing high-quality, reliable and affordable POCT products and services.
Lansion Building
Front Desk
Patent Wall
Office
Leadership Area
Training Area
ONE ENEMY, WHOLE WORLD IS FIGHTING WITH
COVID-19
The Coronavirus (COVID-19) was first reported in Wuhan, Hubei, China in December 2019, the outbreak
was later recognized as a pandemic by the WHO.
Certificate
Contact US
Product Information
Quantity
Unit
Piece
Support order samples, customization, wholesale direct, and complete payment. If the product you look for does not have corresponding customized content, pls fill out the form below to contact us, and we will reply ASAP.